The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it. It's not a replacement for the company’s existing shot, but a second option.

Moderna announced this weekend that the Food and Drug Administration approved its lower-dose Covid-19 vaccine for adults 65 and older, as well as people ages 12 to 64 with at least one medical ...

The FDA has approved a new COVID-19 vaccine developed by Moderna, offering a lower-dose option aimed at older adults and people with underlying health risks. The vaccine, named mNexspike, is part ...

Moderna's mNEXSPIKE COVID-19 vaccine is FDA-approved for high-risk adults, showing improved efficacy over the original vaccine for older populations.

CAMBRIDGE, MA / ACCESS Newswire / May 31, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has approved mNEXSPIKE® (mRNA-1283), a new vaccine ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it. It's not a replacement for the company’s existing shot, but a second option.

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it. It's not a replacement for the company’s existing shot, but a second option.

It's made in a way that allows for a lower dose — a fifth of the dose of its current COVID-19 vaccine, Spikevax — by refining its immune target. The approval “adds an important new tool to help ...

The U.S. approved a new COVID-19 vaccine made by Moderna late Friday but with limits on who can use it. It's not a replacement for the company’s existing shot, but a second option.